Keyphrases
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Risk Factors
22%
Non-alcoholic Fatty Liver Disease (NAFLD)
22%
Pharmacological Agents
22%
Chronic Liver Disease
22%
Health Problems
11%
Diabetes
11%
Obesity
11%
World Population
11%
Cirrhosis
11%
Hepatocellular Carcinoma
11%
Etiological Agents
11%
Fibrosis
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Disease-associated
11%
Weight Loss
11%
Pharmaceutical Agents
11%
Disease Progression
11%
Non-diabetic
11%
Rate of Rise
11%
Disease Management
11%
Hepatitis
11%
Etiological Factors
11%
Economic Burden
11%
Pioglitazone
11%
Metabolic Dysregulation
11%
Vitamin E
11%
Disease Entity
11%
Overweight or Obesity
11%
Diagnostic Techniques
11%
Lifestyle Modification
11%
Dietary Control
11%
Therapeutic Evaluation
11%
Technique Evaluation
11%
Non-cirrhosis
11%
Simple Steatosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Nonalcoholic Fatty Liver
22%
Liver Cirrhosis
22%
Chronic Liver Disease
22%
Liver Cell Carcinoma
11%
Disease
11%
Diabetes Mellitus
11%
Fibrosis
11%
Steatosis
11%
Obesity
11%
Disease Exacerbation
11%
Etiology
11%
Pioglitazone
11%
Alpha Tocopherol
11%
Non Insulin Dependent Diabetes Mellitus
11%